Medication Adherence Market Report 2025

The medication adherence market size has grown rapidly in recent years. It will grow from $3.86 billion in 2024 to $4.29 billion in 2025 at a compound annual growth rate (CAGR) of 11.1%. The growth in the historic period can be attributed to rapid growth in elderly population, strong economic growth in emerging markets, rise in healthcare expenditure, rise in usage of pharmaceuticals, and rising prevalence of cardiovascular diseases.

The medication adherence market size is expected to see rapid growth in the next few years. It will grow to $6.73 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to increasing prevalence of chronic diseases, increasing adoption of smartphones, increasing demand for personalized healthcare technologies, and advances in medicine. Major trends in the forecast period include cloud-based medication adherence, gamification modes especially for children, developing smart pill containers with innovative features, developing medical adherence apps with innovative features, developing wearable sensors, developing ingestible biosensors, focusing on partnerships and collaborations, and focusing on developing innovative products.

The increasing need for solutions addressing medication adherence challenges in the healthcare sector is expected to drive the demand for medication adherence solutions. In April 2022, the International Longevity Centre, an independent UK-based policy think tank focusing on a life-course perspective on social aging and demographic change, reported that medication adherence for chronic illnesses can be as low as 50% in high-income nations and even lower in low-income countries. Non-adherence to prescribed medications incurs significant costs, amounting to approximately $100 billion to $290 billion in the United States, €125 billion ($137.5 billion) in Europe, and AU$7 billion ($4.9 billion) in Australia. To address this issue effectively, patients are increasingly turning to medication adherence solutions, leading to a surge in demand.

The rising prevalence of chronic diseases is anticipated to propel the growth of the medication adherence market in the foreseeable future. Chronic illnesses, characterized by prolonged medical treatment requirements and a hindrance to daily activities, demand consistent medication adherence to prevent disease progression and mortality. Improving adherence to medications can result in better clinical outcomes, reduced healthcare costs, enhanced patient education, and the development of long-term drug adherence initiatives. As of March 2022, the Australian Bureau of Statistics revealed that 78.6% of Australians reported having at least one long-term health concern, with 46.6% (11.6 million) suffering from at least one chronic condition. This escalating incidence of chronic diseases is a driving force behind the medication adherence market.

Leading companies in the medication adherence market are concentrating on innovative developments, such as providing real-time data access for assessing treatment effectiveness and facilitating informed decision-making. Real-time data access enables the immediate retrieval and analysis of data as it is generated or updated, with minimal delay. For example, in June 2024, PatchRx, a U.S.-based medication adherence technology firm, launched PatchRx Connect, which integrates real-time medication adherence data into existing care management platforms. This new tool seamlessly incorporates real-time adherence data, allowing clinical teams to gain insights into patients' medication-taking behaviors without disrupting their workflows. The solution includes a smart device that tracks medication usage and offers actionable insights for healthcare providers, along with patient engagement tools like SMS alerts to improve adherence rates.

Major players in the medication adherence market are also focusing on developing innovations like omnichannel engagement, which enhances refill adherence and encourages behavioral changes among patients. Omnichannel engagement refers to a cohesive, integrated approach to interacting with customers across various channels and touchpoints. For instance, in May 2024, Ushur, a U.S.-based software development company, launched a prebuilt healthcare solution designed to improve medication adherence among patients. This new digital self-service platform aims to automate medication adherence journeys for healthcare organizations. It identifies barriers to adherence, promotes refill compliance, and encourages positive health behaviors, utilizing advanced automation and AI to engage patients at risk of non-adherence through secure, HIPAA-compliant communication channels.

In September 2024, Scriptology, a modern medication management company based in Georgia, acquired RxLive for an undisclosed amount. This acquisition is intended to enhance Scriptology's capabilities in delivering personalized medication management solutions by integrating RxLive's expertise in clinical pharmacist consultations and telehealth services. RxLive is a U.S.-based telehealth pharmacy company dedicated to improving medication adherence through tailored care and support for patients.

Major companies operating in the medication adherence market include Omnicell Inc., Koninklijke Philips N.V., Cardinal Health, McKesson Corporation, Allscripts Healthcare Solutions, Inc., DrFirst.com, Inc., AdhereTech Inc, MedMinder, Caredose, PHC Holdings Corporation, Kakehashi Inc., MedAdvisor International Pty Ltd., InHandPlus Inc., Adherium, mHealth, Aardex Group, Propeller Health, Umotif, Echo, HealthEra, Popit, Tinylogics, Johnson & Johnson Services Inc, TalkingMedicines, Adherence Solutions LLC, SMRxT Inc., emocha, Mobile Health, DIMAGI, INC., Seamless MD, Merck KGaA, AstraZeneca Brasil, Datos Ltd, Vaica, Wisepill Technologies, Novartis AG.

North America was the largest region in the medication adherence market in 2024. Western Europe was the second largest region in the global medication adherence market share. The regions covered in the medication adherence market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medication adherence market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Medication adherence refers to systems that assess whether a person follows the medication prescribed by a healthcare provider, monitoring whether patients take their medications as directed and continue to adhere to a prescribed medication regimen. Medication adherence, both in hardware and software, assists medical professionals in overseeing a patient's medication intake, aiming to reduce instances of disease exacerbation, prevent fatalities, and decrease healthcare costs.

The primary categories of medication adherence are hardware-centric and software-centric. Software-centric medication adherence products comprise programs or applications that monitor, record, and notify the individual and their caregiver about medication compliance. Medications covered include those for cardiovascular, central nervous system, diabetes, oncology, respiratory, gastrointestinal, rheumatology, and others. These products find application in various settings such as hospitals, retail pharmacies, long-term care facilities, and mail-order pharmacies.

The medication adherence market research report is one of a series of new reports that provides medication adherence market statistics, including medication adherence industry global market size, regional shares, competitors with a medication adherence market share, detailed medication adherence market segments, market trends and opportunities, and any further data you may need to thrive in the medication adherence industry. This medication adherence market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Medication adherence market consists of sales of instruments such as smart pill bottles, smart caps, smart medical watches, wearable sensors and others. The market also includes technology associated applications such as cloud-based databases, health programs, patient web portals, mobile medication management applications and others. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.